Get the Weekly Intelligence Brief — top committee picks every Sunday.
ACHC · NASDAQ · STOCK

Acadia Healthcare (ACHC) Stock Analysis

Healthcare Updated September 17, 2026
$28.14
52W $11.43 – $35.83
56/100
$2.55B
-2.2
0.62
AI Committee Verdict
Watch
56/100
Conviction: High · 80% agreement · 5 analysts
+0.5%
-21.0%
0.02:1
High

Is ACHC Bullish or Bearish?

Mixed. Innellis AI committee rates Acadia Healthcare Company, Inc. (ACHC) Watch with a composite score of 56/100 , based on 5 analysts with 80% agreement. Last updated September 17, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +4.50 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -15.50 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee sees neither a compelling opportunity nor a clear risk at this stage. Conditions remain neutral — patience is warranted.

Bull & Bear Case

Bull Case
  • Price-to-book of 0.7x is a discount to asset value — Value
  • 4 consecutive earnings beats -- consistent execution — Growth
Bear Case
  • ROE of only -50.0% -- cheap may mean cheap for a reason — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of September 17, 2026
Overall Committee Score
56/100
Agreement
80%
Analysts
5
Conviction
High
Sector Rank
Top 64%
of 192 Healthcare peers
Value Analyst neutral
55 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Price-to-book of 0.7x is a discount to asset value
− ROE of only -50.0% -- cheap may mean cheap for a reason
Growth Analyst neutral
52 / 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2514.55)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 55.5 to 55.5.

Comparing 2026-09-16 to 2026-09-17 (1 day apart).

Technical Analysis

RSI (14)
37.8
Neutral
MACD Histogram
-0.013
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Support
$21.62
Resistance
$27.50
Bollinger %B
0.27
Inside Bands
Price vs Moving Averages
EMA 9
$28.08 Above
EMA 21
$28.62 Below
EMA 50
$28.96 Below
EMA 200
$26.08 Above

Fundamental Analysis

Valuation
100
Growth
69
Profitability
10
Financial Health
62
Cash Flow
15
Valuation
P/E Ratio -2.2×
P/B Ratio 1.26×
PEG Ratio 0.00
Dividend Yield 0.00%
52W High $35.83
52W Low $11.43
Quality & Growth
ROE -5658.3%
ROA -1995.1%
Gross Margin 3556.5%
Operating Margin 1006.0%
Revenue Growth YoY
Debt / Equity 1.30
AI Fundamental Assessment
P/E ratio of -2.2 (inexpensive relative to a 15-40x range); Price-to-book of 1.3x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -56.6%; Return on assets of -20.0%; Net margin of -33.4%; Gross margin of 35.6%; Current ratio of 1.57 (healthy short-term liquidity); Debt-to-equity of 1.30; Free cash flow per share is negative (-0.21); Most recent quarter beat estimates by 7.4%; 4 consecutive earnings beats; EPS growth decelerating (+428.6% -> +2.7% QoQ); Analyst estimates rising over recent quarters
Get the Full ACHC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime